Chen, X. J. and Parelkar, S. S. and Henchey, E. and Schneider, S. and Emrick, T.. (2012) PolyMPC-Doxorubicin Prodrugs. Bioconjugate Chemistry, 23 (9). pp. 1753-1763.
Full text not available from this repository.Abstract
We demonstrate the conjugation of the cancer drug doxorubicin (DOX) to poly(methacryloyloxyethyl phosphorylcholine) (polyMPC), linked by hydrazone groups, using (1) a one-pot ATRP/click sequence, and (2) a post-polymerization conjugation strategy. While the one-pot method gave polyMPC-DOX conjugates in a facile single step, post-polymerization conjugation gave higher-molecular-weight polymers with very high DOX loadings. DOX release from the polyMPC backbone was pH-dependent (faster at pH 5.0 than at pH 7.4) owing to the hydrazone linkage. Half-life values of DOX release ranged from 2 to 40 h at pH 5.0. Cell culture experiments showed that highly loaded polyMPC-DOX conjugates exhibited higher intracellular drug accumulation and lower half-maximal inhibitory concentration (IC50) values, while a polymer with 30 wt % drug loading showed a maximum tolerated dose in the range of 30-50 mg/kg DOX equivalent weight in healthy mice.
| Item Type: | Article |
|---|---|
| Additional Information: | Chen, Xiangji Parelkar, Sangram S. Henchey, Elizabeth Schneider, Sallie Emrick, Todd |
| Collections: | Nanomanufacturing Research Collection > Nanomanufacturing Nanoscale Science and Engineering Centers > Center for Hierarchical Manufacturing |
| Depositing User: | Robert Stevens |
| Date Deposited: | 26 Mar 2014 |
| Last Modified: | 26 Mar 2014 19:43 |
| URI: | http://eprints.internano.org/id/eprint/2035 |
Actions (login required)
 |
View Item |
